Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery - Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia, 2023
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Diagnostics | Free Full-Text | Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Frontiers | Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis - Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan, 2021
Pancreatic Cancer (Pancreatic Ductal Adenocarcinoma) - CTA
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Flow-diagram of patient identification. Patients with a diagnosis of... | Download Scientific Diagram
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Cancers | Free Full-Text | Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
IJMS | Free Full-Text | Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Cancers | Free Full-Text | Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags | British Journal of Cancer
Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade | Journal of Pancreatology
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review - Yang - 2021 - Cancer Communications - Wiley Online Library
